Lack of evidence for Lrrk2 in α‐synuclein pathological inclusions
- 21 November 2006
- journal article
- Published by Wiley in Annals of Neurology
- Vol. 60 (5), 618-619
- https://doi.org/10.1002/ana.21029
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Kinase activity is required for the toxic effects of mutant LRRK2/dardarinNeurobiology of Disease, 2006
- LRRK2 protein is a component of lewy bodiesAnnals of Neurology, 2006
- LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?Trends in Molecular Medicine, 2006
- Biochemical and pathological characterization of Lrrk2Annals of Neurology, 2006
- Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic PathologyNeuron, 2004
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004